HEALTH ECONOMICS AND POLICY ADVISORY
Established in 2021, Zeumed is a health economics and policy consulting company specialising in advising governments and payers.
Our expertise includes health financing reform, econometric modelling, cost-benefit analysis, health investment opportunities, and health policy evaluation.
We work with
-
national health care payers
-
governments and Ministries of Health (for both emerging and developed economies)
-
insurers and reinsurers
-
NGOs in the health sector
-
entrepreneurs involved in bringing medical technology or devices to market
-
health sector and life science investors
Available Services
Value Based Pricing
At Zeumed, we collaborate with both payers and life science organizations to develop customized Value-Based Pricing (VBP) models. Using econometric techniques, we design robust frameworks tailored to the intervention, carefully selecting outcome measures that matter most to payers and providers, ensuring decisions are backed by strong, evidence-based insights.
Economic Modelling
We design economic models to assess population health, treatments, and care pathways, tailoring each model to the specific disease or intervention. Our expertise spans a range of economic modelling techniques, that align with payer priorities and support sustainable decision-making.
Health Policy
Health policy involves developing strategies that align with regulatory frameworks, address system challenges, and meet the goals of healthcare stakeholders. We help clients refine messaging, analyze policy impacts, and craft evidence-based strategies that resonate with decision-makers, ensuring their initiatives achieve meaningful and measurable outcomes in the health sector.
Negotiations
We assist payers and life science organizations in preparing for critical reimbursement negotiations by providing strategic, data-driven insights. Our tailored support includes reviewing negotiation documents, anticipating counterarguments, and equipping teams with robust evidence to secure fair and sustainable outcomes.
Health System Strengthening
Health system strengthening involves partnering with international organizations and NGOs engaged in building resilient healthcare systems. Zeumed supports these efforts by delivering expertise in health financing, including the design of optimal financing systems and governance frameworks to ensure sustainable and effective healthcare delivery.
Zeumed translates complex economic concepts into actionable insights for decision-makers in healthcare through a structured and targeted approach. Our services include:
-
Health Economic Analysis: Conducting robustness testing of health economic submissions, including value-based payment models, designed for both providers and payers.
-
Strategic Health Financing: Offering expert advice on financing models, population-level budgetary planning, and the development of governance frameworks to enhance strategic purchasing for primary, secondary, and tertiary care.
-
Indicator Development and Negotiation Support: Identifying key performance indicators for payment models and supporting negotiations with the life sciences industry.
-
Digital Health Alignment: Reviewing digital health tenders to ensure alignment with payer priorities and value delivery.
-
Market Entry Strategies: Formulating market entry plans for medtech and medical device companies, integrating national reimbursement strategies into their approach.
-
Investment Reviews: Providing clinical and economic evaluations of healthcare and life science investment opportunities to guide impactful decision-making.
Founder and CEO
Dr Fiona Kiernan
Zeumed was established to address some of healthcare’s most pressing challenges. As a former senior doctor with 17 years of clinical experience and a PhD in Economics, I’ve always been driven by the intersection of health and economics—how policy, funding, and innovation come together to shape the care people receive.
My career has taken me across Ireland, the United Kingdom, France, Germany, and Switzerland, working in diverse healthcare systems and markets. Alongside my deep academic expertise, I bring significant commercial acumen, having advised global healthcare payers, life sciences companies, and ministries of health on pragmatic, real-world solutions to complex problems. This balance of academic rigor and commercial insight ensures that my recommendations are both evidence-based and actionable. My work has been featured in peer-reviewed journals, health industry magazines, industry podcasts, and national media.